Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aranex Animal Health (operating under ARANEX LLP) is an Indian veterinary pharmaceutical company specializing in advanced dermatological and antiparasitic healthcare solutions for companion animals and livestock. The company's product portfolio includes medicated shampoos, topical lotions, anti-itch oils, and wound-healing sprays formulated with active pharmaceutical ingredients (such as mupirocin, fluticasone propionate, ivermectin, and fusidic acid) as well as soothing botanical extracts. Aranex utilizes proprietary technologies like Drug Depot Technology to deliver sustained relief and deep skin penetration for conditions like dermatitis, fungal and bacterial infections, and ectoparasitic infestations. Formulated and manufactured in India, their products are designed to be lick-safe, non-toxic, and pH-balanced to ensure optimal safety and efficacy for dogs, cats, and large animals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aranex Animal Health.